{
  "alleleExist":true,
  "dataVersion":"v4.5",
  "diagnosticImplications":[
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Dx3",
      "pmids":[
        "24345752"
      ],
      "tumorType":{
        "children":{},
        "code":"AITL",
        "color":"LimeGreen",
        "id":264,
        "level":5,
        "mainType":{
          "id":null,
          "name":"Mature T and NK Neoplasms",
          "tumorForm":"LIQUID"
        },
        "name":"Angioimmunoblastic T-Cell Lymphoma",
        "parent":"MTNN",
        "tissue":"Lymphoid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Dx3",
      "pmids":[
        "22237106"
      ],
      "tumorType":{
        "children":{},
        "code":"ETPLL",
        "color":"LimeGreen",
        "id":857,
        "level":4,
        "mainType":{
          "id":null,
          "name":"T-Lymphoblastic Leukemia/Lymphoma",
          "tumorForm":"LIQUID"
        },
        "name":"Early T-Cell Precursor Lymphoblastic Leukemia",
        "parent":"TLL",
        "tissue":"Lymphoid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Dx2",
      "pmids":[
        "21415852"
      ],
      "tumorType":{
        "children":{},
        "code":"MDS",
        "color":"LightSalmon",
        "id":355,
        "level":3,
        "mainType":{
          "id":null,
          "name":"Myelodysplastic Syndromes",
          "tumorForm":"LIQUID"
        },
        "name":"Myelodysplastic Syndromes",
        "parent":"MNM",
        "tissue":"Myeloid",
        "tumorForm":"LIQUID"
      }
    }
  ],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"DNMT3A, a tumor suppressor and DNA methyltransferase, is recurrently mutated in acute myeloid leukemia and other hematologic malignancies.",
  "highestDiagnosticImplicationLevel":"LEVEL_Dx2",
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":true,
  "lastUpdate":"03/13/2023",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "27841873",
        "22722925",
        "24167195",
        "24656771",
        "30291338",
        "27010239",
        "34429321"
      ]
    },
    "description":"The DNMT3A R882H mutation is located in the methyltransferase domain of the DNMT3A protein. This mutation has been recurrently found in leukemias (PMID: 24656771). In vitro studies have demonstrated that this mutation is inactivating as measured by reduced methyltransferase activity, enhanced hypomethylation, and altered chromatin remodeling activity compared to wildtype (PMID: 24656771, 22722925, 27010239, 34429321). Biochemical evidence shows that the R882H mutant protein interacts with wildtype DNMT3A, suggesting dominant negative activity (PMID: 24167195, 24656771). Drug efficacy studies have demonstrated that the R882H mutation may confer resistance to DNA methyltransferase inhibitors and other cytotoxic chemotherapies (PMID: 27841873, 30291338).",
    "knownEffect":"Loss-of-function"
  },
  "oncogenic":"Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"R882H",
    "alterationType":null,
    "consequence":"missense_variant",
    "entrezGeneId":1788,
    "hgvs":null,
    "hugoSymbol":"DNMT3A",
    "id":null,
    "proteinEnd":882,
    "proteinStart":882,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":true,
  "variantSummary":"The DNMT3A R882H mutation is known to be oncogenic.",
  "vus":false
}